ASTRAZENECA PLC (AZN)
Clinical trial NCT06862791 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-25 → 2026-05-11 3. primary completion date: 2026-05-25 → 2026-05-11
Clinical trial NCT06862791 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-25 → 2026-05-11 3. primary completion date: 2026-05-25 → 2026-05-11
KBRA Assigns Rating to Blue Owl Technology Finance Corp.s $500 Million Senior Unsecured Notes due 2029
Clinical trial NCT06411249: allocation: NON_RANDOMIZED → NA.
Clinical trial NCT07214662 updates: 1. completion date: 2030-04-01 → 2030-06-01 2. primary completion date: 2030-04-01 → 2030-06-01
Clinical trial NCT07527832 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-31 → 2026-05-27 3. primary completion date: 2026-05-31 → 2026-05-27 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05319314: enrollment: 30 → 155 participants.
Clinical trial NCT07256392: status: RECRUITING → ENROLLING_BY_INVITATION.
Clinical trial NCT04904549 updates: 1. status: COMPLETED → TERMINATED 2. start date: 2020-08-20 → 2021-05-26 3. enrollment: 23726 → 23670 participants
Clinical trial NCT07484022: start date: 2026-04-01 → 2026-06-01.
Clinical trial NCT07511387 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 40 → 50 participants 3. enrollment type: ESTIMATED → ACTUAL